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Abstract  (currently 273 words, we need to reduce to 250 words) 
Aims: To determine the impact of smoking and alcohol exposure during adolescence on 
arterial stiffness at 17 years. 
Methods and Results: Smoking and alcohol use were assessed by questionnaires at 13, 15 
and 17 years in 1266 participants (425 males and 841 females) from the ALSPAC study. 
Participants were classified as smokers and non-smokers at each period. Smoking intensity 
was assessed as number of cigarettes smoked in lifetime (“high” ≥100, “moderate” 20-99, 
and “low or never” <20 cigarettes in lifetime). Participants were classified as low and high 
frequency drinkers and light (LI < 2), medium (MI 3-9), and heavy (HI > 10 drinks) intensity 
drinkers respectively. Aortic pulse wave velocity (PWV) was assessed in all participants at 17 
years. Estimates for PWV are provided as mean±SD and/or mean difference, 95% confidence 
intervals [CIs].  
Current smokers had higher PWV compared to non-smokers (p=0.003). Higher smoking 
exposure was associated with higher PWV compared to non-smokers (5.81±0.725 versus 
5.71±0.677 m/s, mean adjusted difference 0.211m/s, 95% CIs 0.087/0.334, p=0.001). 
Participants who stopped smoking had similar PWV compared to never smokers (p=0.160). 
High intensity drinkers had increased PWV (HI: 5.85±0.8 versus LI: 5.67±0.604 m/s, mean 
adjusted difference 0.266 [0.055, 0.476] m/s, p=0.013). There was an additive effect of 
smoking intensity and alcohol intensity, so that “high” smokers who were also HI drinkers 
had higher PWV compared to never-smokers and LI drinkers (mean adjusted increase 0.603  
[0.229, 0.978] m/s p=0.002). 
Conclusion: Smoking exposure even at low levels and intensity of alcohol use were 
associated individually and together with increased arterial stiffness. Public health strategies 
need to prevent adoption of these habits in adolescence to preserve or restore arterial health. 
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Introduction 
Higher use of cigarette smoking and consumption of alcohol are associated with increased 
cardiovascular risk in adult life1, 2. Smokers are twice as likely to suffer a myocardial 
infarction compared to people who have never smoked. For alcohol, a J-shaped association 
has been reported, with cardiovascular (CV) benefit for those consuming small or moderate 
amount of alcohol daily. This has however been questioned in recent studies and meta-
analyses 3 which showed that higher intake or binge drinking are associated with increased 
cardiovascular morbidity and mortality4.  
 
Most adult users of alcohol or tobacco first start to try these substances in their early teens 5, 6. 
In the United States, each day approximately 6,000 adolescents, aged 12 to 18 years, smoke a 
cigarette for the first time, and 3,000 adolescents become daily smokers 7. Most of these 
individuals, however, lack understanding of the health risks associated with cigarette 
smoking, both in the short and long term. A large body of research suggests that adolescents 
who participate in one health-risk behavior are more likely to engage in additional risk 
behaviors7. According to the Center of Disease Classification (CDC), 75% of high school 
students report drinking alcoholic beverages at least once 7. The early impact of these 
unhealthy behaviors on contemporary arterial disease is not well documented.  
The Avon Longitudinal Study of Parents and Children was set up in the 1991 to provide 
detailed environmental information on participants from childhood to adolescence and young 
adulthood and to study the impact on their health8. The cohort and study design are described 
in detail elsewhere (http://www.alspac.bris.ac.uk). The cohort has been followed with 
questionnaires through childhood and at regular annual clinics since the age of 7 years. 
Detailed information about alcohol and smoking is available for participants through 
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adolescence from questionnaires, and vascular phenotyping was performed at age 17 years. 
This provided a unique opportunity to assess the impact of exposure to these substances on 
arterial phenotype and CV risk factor profile in young adulthood. 
 
Methods 
Vascular study population 
Our study population consisted of adolescents who attended the vascular clinic assessment in 
ALSPAC Bristol at 17 years (Figure 1). The study was approved by the ALSPAC Ethics and 
Law Committee and written informed consent was obtained from all participants.  
Tobacco use in adolescence  
Information about tobacco use was obtained from questionnaires at ages 13, 15 and 17 years. 
Participants were classified as smokers or no-smokers at each period. Smoking exposure over 
the 5-year period was assessed. Participants who stopped smoking in adolescence were also 
identified.  
Numbers of cigarettes smoked over lifetime were assessed by questionnaire at 17 years and 
participants were classified in three groups to reflect smoking intensity: “high” (≥100 
cigarettes), moderate (20-99 cigarettes) and low/never smokers (<20 cigarettes in lifetime).  
Cotinine levels were not measured. Adolescence exposure to parental smoking (passive 
smoking) was also assessed by questionnaires.  
Alcohol consumption in adolescence  
Information about alcohol consumption was obtained from questionnaires at the ages of 13, 
15 and 17 years and participants were classified as drinkers or non-drinkers at each period. At 
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17 years, more detailed information about patterns of alcohol use was obtained. The 
participants were asked to report the age when they started drinking alcohol, frequency of 
alcohol consumption/ month and intensity of alcohol consumption (number of drinks 
containing alcohol on a typical drinking day, with one drink equating to 8 g of alcohol). 
Heavy (HI), medium (MI) and light (LI) intensity drinkers were defined as subjects 
consuming > 10 drinks, 3-9 drinks and < 2 drinks respectively on a typical day that they were 
drinking alcohol. Preferences for different beverages (ie beer, wine and spirits) were 
evaluated at 17 years by questionnaires, which assessed the number of each of the 
aforementioned drinks consumed in the last 30 days. Participants were classified as never, 
light, moderate and heavy beer, wine or spirit-drinking if they reported no consumption or 
consumption of 1-5, 6-20 and over 20 drinks in the last 30 days, respectively. 
Aortic stiffness 
Pressure-pulse waveforms were obtained using the Vicorder device by placing a 100 mm 
wide blood pressure cuff around the upper thigh to measure the femoral pulse pressure, and a 
30 mm partial cuff around the neck at the level of the carotid artery. To measure carotid to 
femoral pulse wave velocity (PWV), high quality waveforms were recorded simultaneously 
for 3 seconds with the subject in the supine position, and the foot-to-foot transit time was 
determined using an in-built cross-correlation algorithm centred around the peak of the 
second derivative of pressure. All measurements were performed independently by one of 
two trained vascular technicians (inter-observer mean difference (SD difference) 0.2 (0.1) 
m/s).  
Cardiovascular risk factors (Confounders and mediators) 
Blood pressure was measured in the right arm in the seated position using an Omron 705 IT 
oscillometric BP monitor following a 10 min resting period. Three measurements were taken. 
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The mean of the last two values was used for analysis. Heart rate was measured as the 
average of the last 2 readings recorded by the same device. Waist circumference, weight and 
height were measured using a standardized procedure and body mass index (BMI) was 
calculated as weight (kg)/height (metre)2. At 17 years, fasting blood samples were taken; all 
samples were immediately centrifuged and stored at -80oC. Lipid profile (including total 
cholesterol (TC), high density lipoprotein cholesterol (HDL-C), triglycerides), inflammatory 
markers (C-reactive protein (CRP))  were measured as previously described 9. Liver function 
tests, alanine aminotransferase (ALT), aspartate aminotransferase (AST) and gamma-
glutamyl transpeptidase (GGT) were also measured using colorimetric assay (Roche c311 
using the manufacturers calibration and quality control material). Socioeconomic status 
(SES) was assigned based on father’s occupation and was designated from 1 to 5 according to 
National Readership Survey (NRS) grading criteria, with class 5 denoting unskilled workers. 
(http://www.nrs.co.uk/nrs-print/lifestyle-and-classification-data/social-grade). Physical 
activity (PA) was assessed by actigraph accelerometer at 15 years. Time spent in moderate to 
vigorous PA (MVPA) like cycling, swimming, running was calculated, the cut-point being 
four times resting metabolic rate (equivalent to brisk walking). Minutes of MVPA was 
calculated as the average minutes of such activity per valid day of measurement. 
 
Statistical analysis 
Normally distributed descriptive data are expressed as mean± standard deviation (SD). 
Normal distribution of the data was assessed by the Kolmogorov-Smirnov test or graphically 
inspected with histograms and distributional plots. Data with a non-normal distribution were 
log-transformed to approximate normality prior to parametric testing and are expressed as 
median (interquartile range) 10 in descriptive analyses. Categorical variables are expressed as 
N, percentage. Unadjusted comparisons for continuous variables between groups of interest 
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were performed using analysis of variance (ANOVA), with a test for linear trend carried out 
across pre-specified categories. Categorical variables were compared using the chi-squared 
test. Multivariable linear regression analysis was performed to assess the association between 
smoking, alcohol and cardiovascular risk factors and PWV. Numeric estimates for 
comparisons of interest are provided as mean difference  in PWV along with 95% confidence 
intervals [CIs] around the mean difference. Multivariable models were built through an 
unbiased method of a priori variable selection, based on previous medical literature and 
conventional knowledge. In particular, we adjusted the association of smoking and drinking 
behaviour with arterial stiffness for established CV risk factors (i.e. gender, age, family 
history of cardiovascular disease, LDL cholesterol, systolic blood pressure) and exposure 
variables which have previously been associated with increased CV risk and arterial stiffness 
(i.e. parental SES, high-sensitivity CRP, physical activity and parental smoking). 
An interaction effect between gender and smoking/alcohol consumption behaviour was tested 
as well as a potential additive or multiplicative adverse effect of combination of bad 
behaviours on PWV at 17 years (Supplementary file). 
To assess smoking and alcohol exposure across the range of 13-17 years, adolescents with 
complete questionnaires for smoking behaviour and alcohol consumption were included in 
longitudinal analyses (Supplementary file). Longitudinal data for smoking and drinking 
behaviour were assumed to be missing at random. Participants with and without longitudinal 
data on smoking and drinking habits did not differ substantially in anthropometric, 
biochemical and liver function indices as well as in risk factor distribution (Supplementary 
Table 1, 2). CRP and LDL, passive smoking and drinking intensity at 17 years presented a 
substantial proportion of missing values (i.e. 32.4% for biochemical measurements, 52.2% 
 9 
for passive smoking exposure and 14.1% for drinking pattern, respectively). We replaced 
missing data for all aforementioned variables by multiple imputation using the MCMC 
method 11. We imputed 30 datasets after an adequate burn-in period and we used all available 
variables in the multivariate model. Variables with < 5% missing values were not imputed. 
Statistical analysis was performed by STATA package, version 11.1 (StataCorp, College 
Station, Texas USA). We deemed statistical significance at alpha=0.05. 
Results 
Participant characteristics 
At 17 years, 23.8% of participants were smokers. There was no difference in either smoking 
or alcohol use between males and females. In terms of drinking intensity, 154 (14.2%) 
participants drank 0-2 drinks/typical day, 822 (75.6%) participants drank 3-9/typical day and 
111(10.2%) subjects exceeded 10 drinks/typical day. As far as drinking frequency was 
concerned, 724 (66.6%) participants were classified as low frequency drinkers (10 never 
drinkers, 203 monthly or less, 511 drank 2-4 times per month) and 363 (33.4%) as high 
frequency drinkers (316 drank 2-3 times per week and 47 participants drank ≥4 times per 
week.  
The demographic characteristics, according to smoking and alcohol intensity at 17 years, are 
summarized in Table 1. Smoking rates (p=0.012) but not alcohol consumption (p=0.130) in 
adolescence increased progressively from social class I (high status) to V (manual unskilled). 
Parental smoking was associated with smoking in adolescence (p=0.046). Physical activity 
did not differ across smoking and drinking intensity groups. Participants with higher alcohol 
intensity had increased weight but normal BMI, increased TC and mildly deranged liver 
function (i.e. increased ALT) (Table 1). Following adjustment, drinking intensity was still 
related to increased ALT (p=0.014). 
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Patterns of smoking behaviour during adolescence and arterial stiffness 
Current smokers had increased arterial stiffness compared to non-smokers (mean difference 
0.176 [0.058, 0.293] m/s, p=0.003). Number of cigarettes smoked over lifetime (smoking 
intensity) was positively associated with PWV, with “high” intensity smokers having higher 
PWV compared to low/never-smokers (5.81±0.725 versus 5.71±0.677 m/s, mean difference 
0.104 [0.01, 0.199] m/s, p=0.032). This association remained after adjustment for other CV 
risk factors (mean increase in PWV for high smokers equal to 3.7% or 0.211 [0.087, 0.334] 
m/s, p=0.001 as compared to low/never smokers) (Table 2) and passive smoking (p=0.004). 
Following imputation for missing values in covariates of interest (i.e. LDL, CRP, family 
history of CAD, physical activity and passive smoking), the association of smoking intensity 
and increased PWV remained significant (mean increase 0.122 [0.032, 0.212], p=0.008). 
There was no interaction (pfor interaction=0.308) between gender and smoking exposure on 
vascular profile.  
In 661 participants with complete measurements of smoking status at 13, 15 and 17 years, 
longitudinal analysis indicated that subjects who had never smoked (n=269) had lower PWV 
at 17 years compared to those who had been smoking since 13 years (-0.313[-0.01, -
0.618]m/s, p=0.044) and to current smokers (i.e. at 17 years) (-0.196 [-0.034, -0.357]m/s, 
p=0.018). The longitudinal effect of smoking across the period of 13 to 17 years on PWV 
was consistent across categories of increased duration (mean increase in PWV 0.143 [0.047, 
0.239] m/s per category, pfor linear trend=0.004) (Figure 2) (Table 2). Notably, subjects (n=91) 
who smoked between 13 and 17 years but who subsequently stopped, had comparable PWV 
to never smokers (mean difference -0.152 [-0.364, 0.06], p=0.160). When passive exposure to 
smoke was taken into account, increased duration of smoking was still associated with 
increased PWV at 17 years (mean increase in PWV 0.211[0.083, 0.340] m/s per category, pfor 
linear trend=0.002) compared to never smokers. Finally, when missing values for longitudinal 
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smoking status as well as for confounders were imputed, the association of increased duration 
of smoking with PWV at 17 years remained significant (mean expected increase 0.047[0.01, 
0.089] m/s per category, p=0.027) after adjustment. Adolescents who smoked since 13 or 15 
years, presented an adjusted increase of 0.157 [0.01, 0.308] m/s in PWV compared to 
participants who had never smoked (p=0.042)(n=1225)(Table 2). 
Patterns of alcohol consumption during adolescence and arterial stiffness  
There was no association between age of starting drinking alcohol or frequency of drinking 
and PWV, whereas high intensity drinking was associated with increased PWV compared to 
low intensity drinking (HI: 5.85±0.8 versus LI: 5.67±0.604 m/s, mean difference 0.182 
[0.019, 0.346]m/s, p=0.029). This association remained after adjustment for CV risk factors 
(relative mean increase 4.7% or 0.266[ 0.055, 0.476] p=0.013) (Table 2). Complete analysis 
for imputed observations of drinking intensity at 17 years and additional exposure variables, 
including physical activity, revealed a similar association with increased PWV (p=0.048) but 
additional adjustment for family history of CAD and parental smoking attenuated this effect 
(p=0.059). An interaction effect between gender and alcohol consumption towards arterial 
stiffness was not established (p=0.230). Increased drinking intensity as a proxy to binge 
drinking (≥10 drinks on a typical drinking day) correlated with increased arterial stiffness 
(5.85±0.8 versus 5.7±0.625 m/s, mean increase 0.147 [0.016, 0.279], p=0.028), even after 
controlling for the effect of gender, SBP, SES, LDL, BMI, CRP (mean increase 0.231[ 0.057, 
0.405]m/s, p=0.01).  
In terms of drinking preferences, adolescents in our study consumed more beer drinks 
compared to wine- based drinks (p<0.001) across a period of one month at 17 years. There 
was no difference between consumption of beer- and spirit-based drinks (p=0.426). Three 
hundred twenty-seven (26.7%) adolescents did not drink beer while 414 (33.8%), 371 
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(30.3%) and 112 (9.15%) were light, moderate and heavy beer-drinkers. Wine drinking 
categories were as follows: 558 subjects (46.5%) did not consume wine, 458 (38.2%), 158 
(13.16%) and 26 (2.17%) were light, moderate and heavy wine drinkers respectively. Finally, 
264 (21.48%) participants abstained from spirits in the last month, while 518 (42.14%), 372 
(30.27%) and 75 (6.1%) adolescents were light, moderate and heavy spirit-drinkers.  
Light and moderate wine drinking were associated in univariate analysis with decreased 
arterial stiffness (5.67±0.677 m/s for light and 5.61±0.649 m/s for moderate versus 
5.77±0.684m/s for no consumption, p=0.02 and p=0.008 respectively). Moderate and heavy 
consumption of beer were related to increased PWV (5.66±0.672 m/s for moderate and 
5.79±0.690m/s for heavy versus PWV: 5.62±0.597 m/s for no consumption, p=0.001 and 
p<0.001, respectively) as compared to non-consumption. However, these associations lost 
their significance following adjustment for confounding exposure variables (p>0.05 for all 
categories). Spirit drinking pattern was not associated with arterial stiffness at 17 years in our 
study. In longitudinal analysis the drinking pattern was not associated with PWV (p>0.05 for 
all categories) (Table 2). 
Higher alcohol intensity and smoking intensity had an additive effect on arterial stiffness 
(high alcohol and smoking versus never smokers and low alcohol; 5.89±0.857 versus 
5.61±0.589, mean increase 0.277m/s [0.028, 0.525], p=0.029) compared to never smoking 
and low alcohol consumption. After adjustment, the combined index of alcohol and smoking 
intensity remained an independent predictor of PWV (mean increase 10.8% or 0.603 [0.229, 
0.978] m/s in PWV, for adolescents with both high alcohol and smoking versus never 
smokers and low alcohol, p=0.002) (Table 2) (Figure 3). The association of the combined 
index of alcohol and smoking intensity with increased PWV remained significant after 
additional adjustment for parental smoking (p<0.001) or imputation for missing values in 
confounders at 17 years (mean increase 0.331[0.094, 0.568], p=0.006)(Table 2). There was a 
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non-multiplicative combined effect of these unfavorable behaviors for the vascular profile of 
adolescents (p for interaction>0.1 in both unadjusted and adjusted models, likelihood ratio 
test p>0.1 for the addition of the interaction terms smoking*drinking intensity over the core 
model). 
 
Discussion  
This study demonstrates that smoking and alcohol use up to the age of 17 years have both 
independent and additive associations with arterial stiffness, a marker of vascular damage 
that predicts later CV disease and events.  Smoking in youth, even at low levels, was 
associated with increased aortic stiffness, but stopping this unhealthy behaviour during 
adolescence could restore arterial health.  In addition to smoking, patterns of alcohol use had 
a significant impact on arterial stiffness with higher intensity, rather than frequency of 
consumption, showing the greatest adverse effect on aortic pulse wave velocity. These data 
demonstrate the importance of further public health measures, which focus on preventing the 
establishment of unhealthy behaviours in children and adolescents. 
The links between smoking and excessive alcohol use with adverse CV outcomes in adults 
are well established12, 13. While most adult users of alcohol or tobacco first tried these “drugs” 
during their early teens, the impact of smoking and alcohol consumption on the 
atherosclerotic process at this early stage of the life course is less clear. To evaluate the 
development of early atherosclerosis, we chose to measure carotid to femoral pulse wave 
velocity (PWV) to assess aortic stiffness in a well-characterised cohort of 17 year olds. 
Previous studies have demonstrated that PWV is reproducible and, in adults, predicts CV 
outcomes independently from conventional risk factors14.  
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Epidemiological studies have consistently demonstrated that acute and chronic cigarette use 
adversely affects vascular health in adulthood and promotes atherosclerosis progression15. 
We quantified exposure to cigarettes during adolescence and also assessed smoking 
frequency. Both current cigarette use and chronic smoking exposure had an adverse effect on 
arterial stiffness. This finding is consistent with other reports that demonstrate that the longer 
and earlier a person starts smoking, the higher the incidence of coronary artery disease and 
hypertension and the worse the impact on life expectancy 16. Passive smoking has 
consistently been shown to adversely affect arterial health in the young, however no 
association with aortic stiffness in adolescence was demonstrated in our cohort17. Exposure to 
parental smoking at home was assessed as binary variable and this has precluded us from 
evaluating potential differences in the impact of the degree of passive exposure on aortic 
stiffness.  
The pathophysiological mechanisms linking smoking to vascular disease are still not fully 
elucidated18, 19. Tobacco contains a number of toxic and vasoactive compounds, which can 
exert a direct adverse effect on vascular endothelium and can activate inflammatory and 
thrombotic pathways relevant to CV events18. Although cigarette smoking is discouraged in 
many countries with legislation and other initiatives, the results of our study confirm that 
smoking continues to be prevalent in adolescence in both sexes in the UK.  Accounting for 
total number of cigarettes smoked, it was interesting that only a small percentage of our 
cohort was in the highest smoking category of >100 cigarettes in total.  This is considerably 
less exposure than that of typical adult smokers, in whom life time exposure is measured in 
pack-years (20 cigarettes/day for 1 year). These data are consistent with a recent NHS 
survey, which demonstrated that the number of children trying cigarettes has fallen by three 
quarters since 2003. However, even at these low levels of smoking exposure, we could detect 
an adverse effect on arterial stiffness even when adjusted for other CV risk factors. 
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Interestingly, quitting smoking in adolescence could restore aortic stiffness, emphasizing the 
benefit and opportunity from implementing interventional and educational strategies in the 
young to preserve arterial health consistent with the recent European CV prevention 
guidelines13.  
There are conflicting findings on the impact of alcohol consumption on the vasculature. 
Alcohol intake has been shown to prevent atherosclerosis in some animal studies 20, 21, but not 
in all 22, 23.  Furthermore, results from clinical studies investigating the vascular effects of 
alcohol consumption are inconsistent 24-26. High alcohol intake (>34g/day) is associated with 
higher blood pressure, but observational evidence does not support an association of alcohol 
intake with blood pressure below this level 27. Mild alcohol consumption, up to 2 alcoholic 
beverages per day, can independently improve endothelial function both in young healthy 
subjects and in those with type 2 diabetes 28, 29. In contrast, a Finnish study reported a direct 
linear adverse effect of alcohol consumption on carotid intima media thickness in the young, 
from as little as 2 alcoholic drinks per day 30. In support of this, a recent Mendelian 
randomization meta-analysis implicated alcohol consumption as a causal factor for CV 
disease12. 
In our study, we used a combination of frequency and intensity questionnaires to describe 
better patterns of alcohol use. The age at which participants started consuming alcohol was 
not associated with vascular stiffness, suggesting that duration of exposure might not be that 
important at this young age and this was confirmed in our longitudinal analysis. In contrast, 
higher intensity rather than frequency of alcohol consumption had the greatest adverse 
relationship with arterial stiffness.  This finding is of particular concern since excessive 
drinking, with the aim of getting drunk, is increasingly the norm for teenagers 31. 
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The mechanistic link between alcohol and arterial stiffness is not well explored. Light to 
moderate alcohol consumption is associated with an increase in HDL cholesterol, a decrease 
in inflammatory mediators and improvement in metabolic pathways 32-35. In contrast, excess 
alcohol consumption has been associated with elevation in blood pressure, autonomic 
dysregulation and derangements in coagulation and fibrinolytic pathways 32. In our study, we 
did not find any beneficial effect of alcohol consumption on arterial stiffness even at lower 
consumption levels. Once we analysed separately the different alcoholic beverages, we were 
able to demonstrate that light and moderate wine drinking groups were associated with lower 
PWV, consistent with a beneficial effect, whereas beer drinkers had higher PWV. However, 
these associations lost their significance in multivariable analysis which implies that drinking 
intensity rather than type of alcoholic beverage may be more influential on arterial stiffness. 
The association between alcohol use and CV risk factors was modest and only mild 
derangements in liver function tests were noted in participants with high alcohol intensity 36. 
Interestingly, lower heart rate was noticed in adolescents with high drinking intensity and this 
might represent autonomic dysregulation37.  
Our study has limitations, which should be considered when interpreting our results. The 
study is observational so that causal associations between smoking, alcohol exposure and 
arterial stiffness cannot be established. We relied on self-reported confidential questionnaires, 
collected every 2 years through adolescence, without any biomarker-based assessment of 
smoking or alcohol exposure. Although self-report of smoking and alcohol behaviour has 
been shown to be a valid measure compared to biochemical measures, we cannot exclude the 
possibility that some of our participants may have been misclassified, particularly those from 
the heavier exposure categories; however, such a misclassification would be likely to result in 
underestimation of the effect sizes observed.  The presence of unmeasured or residual 
confounders on our results cannot be excluded. In addition, a number of missing data were 
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imputed in order not to reduce the power of our multivariable longitudinal analysis. 
Imputation of missing values is a well- established statistical approach. Nevertheless, despite 
these limitations, we were able to demonstrate important associations between patterns of 
smoking and drinking use in adolescence with arterial stiffness.  
In summary, in this large contemporary British cohort of adolescents, we have demonstrated 
that drinking intensity and smoking in adolescence, even at lower levels compared to those 
reported in adult studies, is associated with arterial changes relevant to atherosclerosis 
progression. The effect of these unhealthy behaviours was independent of one another and 
additive. Smoking cessation in adolescence was associated with normalization of aortic 
stiffness. These findings have significant public health implications and provide further 
support for public health measures to discourage young adults adopting smoking and drinking 
habits and the benefit of discontinuing these unhealthy behaviours. 
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Figure 1: Study population.  
Flow chart shows the number of participants who responded to questionnaires exploring 
smoking and alcohol use from 13-17 years. 
Figure 2: The longitudinal association between smoking exposure and arterial stiffness 
Increased smoking exposure was associated with higher aortic pulse wave velocity (PWV) 
compared to those who had never smoked. Participants who quit smoking had similar PWV 
compared to those who never smoked.  
*p<0.05 
Figure 3: The combined effect of smoking over lifetime and intensity of drinking on 
arterial stiffness. 
The combination of high intensity drinking with lifetime smoking exposure is shown. Pulse 
wave velocity (PWV) measurements are expressed as mean values and 95% confidence 
intervals around the mean on the x axis. The participants who had high drinking intensity and 
“high” smoking exposure had the highest pulse wave velocity. Asterisk indicates statistically 
significant (p<0.05) difference in PWV as compared to the reference category (low lifetime 
smoking exposure and low drinking intensity). No correction for multiple comparisons has 
been performed. 
 
 
 
 
